Orchestra BioMed | 10-Q: Q3 2024 Earnings Report
Orchestra BioMed | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.1%)
Orchestra BioMed | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.1%)
Orchestra BioMed | 4: Statement of changes in beneficial ownership of securities-Officer Hochman David P
Orchestra BioMed | 4: Statement of changes in beneficial ownership of securities-Officer Sherman Darren
Orchestra BioMed | 4: Statement of changes in beneficial ownership of securities-Director Fain Eric S
Orchestra BioMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Orchestra BioMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Orchestra BioMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Orchestra BioMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Orchestra BioMed | 4: Statement of changes in beneficial ownership of securities-Officer Sherman Darren
Orchestra BioMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Orchestra BioMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Orchestra BioMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Orchestra BioMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Orchestra BioMed | 4: Statement of changes in beneficial ownership of securities-Officer Hochman David P
Orchestra BioMed | 8-K: Current report
Orchestra BioMed | 424B5: Prospectus
Orchestra BioMed | 10-Q: Q2 2024 Earnings Report
Orchestra BioMed | 4: Statement of changes in beneficial ownership of securities-Director Mack John Prosper
No Data
No Data